QNRX
Quoin Pharmaceuticals
QNRX • NASDAQ
Quoin Pharmaceuticals is a pharmaceutical preparations company trading on NASDAQ, led by CEO Michael Myers.
CEOMichael Myers
Next Earnings
Upcoming earnings announcement for Quoin Pharmaceuticals
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$3.92
Earnings History
Past 12 earnings reports for Quoin Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$1.74Est: -$4.98 | +65.1% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$6.71Est: -$3.70 | -81.4% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$6.28Est: -$5.46 | -15.0% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$6.50Est: -$4.20 | -54.8% | - | — | 10-Q |
| Mar 13, 2025 | Q4 2024 | -$0.35Est: -$0.43 | +18.6% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.47Est: -$0.49 | +4.1% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.39Est: -$0.61 | +36.1% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$1.11Est: -$0.76 | -46.1% | - | — | 10-Q |
| Mar 13, 2024 | Q4 2023 | -$2.08Est: -$2.31 | +10.0% | - | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$1.95Est: -$2.72 | +28.3% | - | — | — |
| Aug 2, 2023 | Q2 2023 | -$2.13Est: -$2.82 | +24.5% | - | — | 10-Q |
| May 8, 2023 | Q1 2023 | -$4.08Est: -$3.36 | -21.4% | - | — | — |